Ledger.Open graph →

SEC Form D · filed September 21, 2018

ENB Therapeutics, Inc

Offering

$9.1M

Sold

$2.3M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

NEW YORK, NY

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Stephen Buchanan · Charlotte, NCExec Joseph Strycharz · Charlotte, NCExec · Director Bridget M. Cole · WALTHAM, MADirector William Hayes · Charlotte, NCDirector James Howes · Sydney NSW, Channel IslandsDirector Andrew White · SANTA FE SPRINGS, CADirector Tejroop S. Sehmi · SANTA FE SPRINGS, CAExec · Director Navjot S. Sehmi · SANTA FE SPRINGS, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗